De novo lipogenesis pathway is a vulnerability in IDH1 mutant glioma
L. S. Elahi, M. Condro, R. Kawaguchi…·H. Kornblum
This study identifies de novo lipogenesis as a vulnerability in IDH1 mutant gliomas, showing that HDAC inhibition and FASN targeting reduce tumor growth and improve survival.